Peter Ho

Nhà nghiên cứu Hồ sơ 5/10

68 công bố · 2.826 trích dẫn · h-index 26

Thông tin

🏛️Nơi công tác: Bệnh viện Chợ Rẫy
🔬Lĩnh vực: Y - Dược
✍️Hồ sơ chưa đầy đủ — bổ sung thông tin

Chỉ số h-index 26 xếp học giả này vào lĩnh vực Y - Dược, thuộc nhóm 5% dẫn đầu trong 6.619 hồ sơ cùng lĩnh vực của danh bạ này.

Công bố tiêu biểu

Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study621 trích dẫn
The Lancet Oncology · 2018 · DOI

Truncated ErbB2 receptor (p95ErbB2) is regulated by heregulin through heterodimer formation with ErbB3 yet remains sensitive to the dual EGFR/ErbB2 kinase inhibitor GW572016253 trích dẫn
Oncogene · 2004 · DOI

Regulatory Approvals of Pediatric Oncology Drugs: Previous Experience and New Initiatives228 trích dẫn
Journal of Clinical Oncology · 2003 · DOI

Selective Killing of SMARCA2- and SMARCA4-deficient Small Cell Carcinoma of the Ovary, Hypercalcemic Type Cells by Inhibition of EZH2: In Vitro and In Vivo Preclinical Models172 trích dẫn
Molecular Cancer Therapeutics · 2017 · DOI

Phase I Dose Escalation and Pharmacokinetic Study of Lapatinib in Combination With Trastuzumab in Patients With Advanced ErbB2-Positive Breast Cancer119 trích dẫn
Journal of Clinical Oncology · 2008 · DOI

A randomised, phase II study of intetumumab, an anti-αv-integrin mAb, alone and with dacarbazine in stage IV melanoma118 trích dẫn
British Journal of Cancer · 2011 · DOI

Prenatal Detection of Neuroblastoma: A Ten-Year Experience From the Dana-Farber Cancer Institute and Children's Hospital110 trích dẫn
PEDIATRICS · 1993 · DOI

Final Report of Phase 1 Study of the DOT1L Inhibitor, Pinometostat (EPZ-5676), in Children with Relapsed or Refractory MLL-r Acute Leukemia89 trích dẫn
Blood · 2016 · DOI

Safety, tolerability and pharmacokinetics of oral administration of GW786034 in pts with solid tumors74 trích dẫn
Journal of Clinical Oncology · 2005 · DOI

A first in human study of SB-743921, a kinesin spindle protein inhibitor, to determine pharmacokinetics, biologic effects and establish a recommended phase II dose73 trích dẫn
Cancer Chemotherapy and Pharmacology · 2010 · DOI

Về lĩnh vực Y - Dược

6.619học giả

91.896công bố

2.589.484trích dẫn

4.2h-index trung bình

Hướng nghiên cứu phổ biến trong lĩnh vực:

Mosquito-borne diseases and controlAntibiotic Resistance in BacteriaTuberculosis Research and EpidemiologyMalaria Research and ControlCOVID-19 and Mental HealthHIV/AIDS Research and Interventions

Nơi có nhiều học giả lĩnh vực này nhất: